 |
|
|
| |
Impact of a "one-stop" simplified diagnosis-monitoring strategy on Glecaprevir/Pibrentasvir (G/P) treatment initiation and response in patients with chronic hepatitis C virus(HCV) infection receiving Opioid-Substitute Therapy (OST) in Israel - A Real World Evidence, retrospective analysis
|
| |
| |
EASL 2024 June 5-8
Eli Zuckerman, Orly Azulay, Eyal Ashkenazie, Yulia Kovalev, Carmel Medical Center, Technion Faculy of Medicine, Haifa, Israel Eli Zuckerman, Orly Azulay, Eyal Ashkenazie, Yulia Kovalev Carmel Medical Center, Technion Faculy of Medicine, Haifa, Israel
|
| |
|
|
|
|
|
